NCT00971035View on ClinicalTrials.gov

A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids

PHASE2CompletedINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

February 28, 2011

Conditions

Asthma

Interventions

DRUG

lebrikizumab (MILR1444A)

Subcutaneous repeating dose

DRUG

lebrikizumab (MILR1444A)

Subcutaneous repeating dose

DRUG

lebrikizumab (MILR1444A)

Subcutaneous repeating dose

DRUG

placebo

Subcutaneous repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT00971035 - A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids | Biotech Hunter | Biotech Hunter